ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NKGN NKGen Biotech Inc

1.70
0.13 (8.28%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -732k-969k-403k-636k-955k-2.68M-16.78M-12.76M
Pre Tax Income 2M4.67M1.07M-2.75M783k-1.54M-48.59M-33.6M
Net Income 2M4.68M888k-3.02M379k-1.83M-47.9M-33.61M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -732k-969k3.5M-4.36M-955k-2.68M-21.04M-9.43M
EBITDA -732k-969k-403k-636k-955k-2.68M-15.88M-12.56M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -2.51M-2.74M-33.08M
Pre Tax Income -991k4.99M-82.95M
Net Income -991k4.55M-82.95M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.2310.212-3.79
EBIT -6.67M-2.56M-34M
EBITDA -2.51M-2.74M-31.98M